David H. Kirn
Alameda Applied Sciences Corporation (United States)(US)Therapeutics Clinical Research(US)University of California, Berkeley(US)
Publications by Year
Research Areas
Virus-based gene therapy research, CAR-T cell therapy research, Cancer Research and Treatments, Viral Infectious Diseases and Gene Expression in Insects, RNA Interference and Gene Delivery
Most-Cited Works
- → An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells(1996)1,754 cited
- → A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer(2000)1,100 cited
- → ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents(1997)946 cited
- → An essential role for Rac in Ras transformation(1995)884 cited
- → Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer(2013)762 cited
- → An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy(2000)584 cited